98 related articles for article (PubMed ID: 6280337)
21. Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice.
Klein RJ; Buimovici-Klein E; Moser H; Moucha R; Hilfenhaus J
Arch Virol; 1981; 68(2):73-80. PubMed ID: 6264897
[TBL] [Abstract][Full Text] [Related]
22. Immunological studies of herpes simplex virus infection in children with atopic eczema.
Goodyear HM; McLeish P; Randall S; Buchan A; Skinner GR; Winther M; Rolland J; Morgan G; Harper JI
Br J Dermatol; 1996 Jan; 134(1):85-93. PubMed ID: 8745891
[TBL] [Abstract][Full Text] [Related]
23. Immune responses to herpes simplex virus in patients with facial herpes simplex and those with eczema herpeticum.
Vestey JP; Howie SE; Norval M; Maingay JP; Neill WA
Br J Dermatol; 1988 Jun; 118(6):775-82. PubMed ID: 2840941
[TBL] [Abstract][Full Text] [Related]
24. [The detection and quantitative analysis of viral antigens, infiltrating mononuclear cells, IFN-gamma, LT and IL-6 bearing cells in the frozen brain tissue sections from a patient with herpes simplex encephalitis by immunocytochemistry].
Nakamura S; Shimazaki S; Yoshioka M; Nagano I; Sekizawa T; Kogure K
No To Shinkei; 1990 Apr; 42(4):377-82. PubMed ID: 2167712
[TBL] [Abstract][Full Text] [Related]
25. Cell-mediated immune response to herpes simplex virus: type-specific lymphoproliferative responses in lymph nodes draining the site of primary infection.
Jacobs RP; Aurelian L; Cole GA
J Immunol; 1976 Jun; 116(6):1520-5. PubMed ID: 58037
[TBL] [Abstract][Full Text] [Related]
26. In vitro studies on the human cellular immune response to commercially available herpes simplex antigens.
Czarnetzki BM; Macher E
Arch Dermatol Res; 1980; 268(3):247-55. PubMed ID: 7212769
[TBL] [Abstract][Full Text] [Related]
27. The proliferative T cell response to herpes simplex virus (HSV) antigen is restricted by self HLA-D.
Berle EJ; Thorsby E
Clin Exp Immunol; 1980 Mar; 39(3):668-75. PubMed ID: 6247109
[TBL] [Abstract][Full Text] [Related]
28. Fixed herpes simplex type 1-infected cells as antigen for in vitro lymphocyte proliferation.
Welling-Wester S; Huitema BA; Wilterdink JB
J Immunol Methods; 1985 Feb; 76(2):239-46. PubMed ID: 2982955
[TBL] [Abstract][Full Text] [Related]
29. HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes.
Maccario R; Revello MG; Comoli P; Montagna D; Locatelli F; Gerna G
J Immunol; 1993 Feb; 150(4):1437-45. PubMed ID: 8381835
[TBL] [Abstract][Full Text] [Related]
30. Cell-mediated immunity to herpes simplex virus in man.
Russell AS
Am J Clin Pathol; 1973 Dec; 60(6):826-30. PubMed ID: 4357123
[No Abstract] [Full Text] [Related]
31. Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay.
Lopez C; O'Reilly RJ
J Immunol; 1977 Mar; 118(3):895-902. PubMed ID: 191528
[TBL] [Abstract][Full Text] [Related]
32. HLA-Dw2-related hyporesponsiveness to herpes simplex antigen in multiple sclerosis.
Paty DW; Cousin HK; Stiller CR; Boucher DW; Warren KG; Dossetor JB
Trans Am Neurol Assoc; 1977; 102():49-51. PubMed ID: 210554
[No Abstract] [Full Text] [Related]
33. Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.
Donnenberg AD; Chaikof E; Aurelian L
Infect Immun; 1980 Oct; 30(1):99-109. PubMed ID: 6254886
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte interferon production and transformation after Herpes simplex infections in humans.
Rasmussen LE; Jordan GW; Stevens DA; Merigan TC
J Immunol; 1974 Feb; 112(2):728-36. PubMed ID: 4360547
[No Abstract] [Full Text] [Related]
35. Effects of herpes simplex virus antigens on human mixed lymphocyte culture.
Singal DP; Rawls WE
Transplantation; 1980 Jun; 29(6):500-2. PubMed ID: 6250256
[No Abstract] [Full Text] [Related]
36. HLA antigen frequency in erythema multiforme and in recurrent herpes simplex.
Middleton D; Hutchison TH; Lynd J
Tissue Antigens; 1983 Mar; 21(3):264-7. PubMed ID: 6574617
[TBL] [Abstract][Full Text] [Related]
37. Cell mediated immunity to herpes simplex in man. IV. A correlation of lymphocyte stimulation and inhibition of leukocyte migration.
Russell AS; Kaiser J; Lao VS
J Immunol Methods; 1976; 9(3-4):273-9. PubMed ID: 175120
[TBL] [Abstract][Full Text] [Related]
38. Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens.
Kalimo KO; Joronen IA; Havu VK
Infect Immun; 1983 Jan; 39(1):24-8. PubMed ID: 6295957
[TBL] [Abstract][Full Text] [Related]
39. [HLA typing of patients with herpes simplex recidivans and postherpetic erythema exsudativum multiforme].
Simon M; Djawari D; Schönberger A
Z Hautkr; 1984 Aug; 59(16):1087-9. PubMed ID: 6333113
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
